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Cardiac arrhythmias are caused by disordered propagation of electrical activity.  Progress in 
understanding and controlling arrhythmias requires novel methods to characterize and control 
the spatiotemporal propagation of electrical activity.  We used patterned illumination of 
cardiomyocytes derived from optogenetic human induced pluripotent stem cells to create 
dynamic conduction blocks, and to test spatially extended control schemes.  Using this 
model, we demonstrated the ability to initiate, circumscribe, relocate, and terminate 
pathologic spiral waves that drive many arrhythmias. When cells were derived from patients 
with long QT syndrome, longer action potential durations made spiral waves more resistant to 
termination.  This work lays the foundation for personalized models of cardiac injury and 
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Heart disease remains the leading cause of death in the United States, accounting for ~25% of 
total deaths 1. Sudden cardiac death currently accounts for 400,000 deaths every year in the 
United States,2 many of which can be attributed to a variety of arrhythmias, which are 
disorders in the propagation of electrical activity in the heart.  Due to the intrinsically 
spatiotemporal nature of arrhythmias, their behavior depends critically on the geometry and 
electrophysiological properties of the myocardial substrate.  In particular, the normal orderly 
propagation of planar wavefronts through the heart can be perturbed through anatomic3 and 
electrophysiological defects,4,5 leading to aberrant waveforms such as spirals that can drive 
tachycardia and fibrillation.   
1.2 Reentry 
Arrhythmia mechanisms can be divided along a number of different axes.  We focus here on 
the distinction between reentrant and nonreentrant activity.  Nonreentrant arrhythmias include 
those caused by focal activity such as enhanced automaticity or triggered activity.  Reentry 
occurs when propagating action potentials fail to extinguish and instead reactivates a region 
that has recently returned to a resting state.  Reentry can be further divided into two types: 
anatomic and functional.  The theoretical and experimental background for the modern 
understanding of reentry as a self-sustaining dynamic equilibrium dates back to 1887,6 with 
additional publications following after the turn of the century. 
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1.2.1 Anatomic reentry 
Anatomic reentry can be described as the unidirectional circulation of electrical activity 
around a ring of cardiac tissue.  Inspired by similar experiments performed in jellyfish in 
1906,7 G. R. Mines demonstrated the first instance of what was later termed the ‘circus 
movement hypothesis of reentry’ in cardiac tissue in 1913.  He showed that self-sustaining 
unidirectional waves of contraction could circulate indefinitely around rings cut from tortoise 
hearts (Figure 1.1), and suggested that they could form the basis for cardiac fibrillation.8  
Today, we know that anatomically defined reentry is related to a number of different 
arrhythmias with various mechanisms, such as the presence of accessory pathways in Wolf-
Parkinson-White, or by the presence of scar tissue secondary to myocardial infarction.9  
Anatomic reentry requires that the cycle length for a wavefront traveling around the circuit 
must be longer than the refractory period, such that the wave does not collide with itself and 
extinguish. 
 
Figure 1.1 Heart ring used by Mines to demonstrate anatomic reentry, and 
accompanying illustrations of reentrant circuits8 




Figure 1.2 Functional reentry documented by Allessie et al10 
In contrast to anatomic reentry, functional reentry occurs without the presence of an anatomic 
obstacle.  Functional reentry was first demonstrated in 1973 by Allessie et al (Figure 1.2),10 
though conceptually it had been suggested several decades prior in parallel with the 
experimental work demonstrating anatomic reentry.11 A follow-up paper in 1977 introduced 
the “leading circle hypothesis” to explain re-entrant activity without an anatomic obstacle 
(Figure 1.3).12  This theory postulated that functional reentry occurred around a functional 
obstacle, which was maintained in a permanently refractory state due to encroaching waves 
from the circulating wave.  In comparison to anatomic reentry, the period of rotation is 
defined not by the path length, but by the intrinsic electrophsyiologic properties of the tissue 
governing the conduction velocity and refractory period.  While promising, this theory was 
ultimately supplanted as it was unable to adequately explain the dynamics of fibrillation, 
particularly the drift and meander of the circulating wave front that is precluded by the 
presence of a stationary, permanently refractory functional obstacle.  
 
Figure 1.3 Leading circle hypothesis12 
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Further insight would eventually arrive from the study of similar vortex-like phenomena 
found in other types of excitable media, termed spiral waves in two-dimensional substrates.13  
A general mathematical theory for the behaviour of spiral waves in excitable media has been 
established using insights gained from this collection of systems.  Spiral waves are governed 
by the relationship between the current source (excited cells at the leading edge of the wave) 
and the current sink (the quiescent, excitable cells just beyond the wavefront).  The smaller 
the source-sink ratio, the lower the conduction velocity, and the shorter the action potential 
duration.  This mismatch is greatest at the tip of the spiral, and gradually diminishes along the 
length of the wave.  The gradient in conduction velocity goes hand-in-hand with the convex 
curvature of the wave, with the greatest curvature and lowest conduction velocity at the 
center of the spiral, where the value of the source-sink relationship is critical, and excitation 
fails.  This leaves an excitable, but nonexcited core also known as the phase singularity 
(Figure 1.4), since all phases meet at this location.14  It is generally understood that the phase 
singularity acts as the source of the spiral wave since elimination of the phase singularity is 
necessary and sufficient for elimination of the corresponding spiral wave.  The source of the 
spiral is also termed a rotor, though in practice the terms rotor, phase singularity, and spiral 




Figure 1.4: Spiral wave schematic14 
1.3 Initiation and termination of reentry 
The characterization of reentry above as a dynamic equilibrium implies a steady state once 
reentry is established.  However, we must be able to enter and exit from this equilibrium.  
The mechanisms are heterogeneous and varied, but a short discussion of simple cases is 
warranted. 
1.3.1 Initiation and termination of anatomic reentry 
As previously discussed, anatomic reentry requires the presence of multiple paths with 
sufficient length.  Additionally, initiation of anatomic reentry also requires the presence of 
unidirectional conduction block on one of the paths.  This can occur through a confluence of 




Figure 1.5 Unidirectional block and reentry initiation (adapted from the Cellular Basis 
for Cardiac Arrhythmias,15 which modified a figure from BG Katzung’s Basic and 
Clinical Pharmacology16) 
Termination of anatomic reentry requires destruction of the circulating waveform.  This can 
be accomplished pharmacologically, such as by action potential duration elongation to 
increase the wavelength beyond the length of the circuit, or through external pacing directly 
interfere with the propagating wave.  However, as long as the circuit exists, re-entrant activity 
is likely to recur.  Permanent solutions often involve the use of catheter ablation to destroy 
the accessory pathway such as in the treatment of Wolff-Parkinson White.17 
1.3.2 Initiation and termination of functional reentry 
Spiral waves arise when the interaction of a wavefront with an obstacle leads to wavebreak, 
which generates the isolated tips necessary for spiral wave formation.  In homogeneous 
media, this can be a transient functional obstacle created by the refractory wake of a previous 
wavefront, as seen in spiral wave induction through the S1-S2 stimulation protocol (also 




Figure 1.6 S1-S2 stimulus protocol induces wavebreak and spiral wave formation18 
Anatomic heterogeneities, caused by the native structure of the heart or by pathologies such 
as myocardial infarctions or structural remodelling, can also induce wavebreak and spiral 
wave formation.  A prominent experimental demonstration of wavefront instabilities caused 
by wave interactions with conduction blocks in heart tissue occurred in 1996, with the 
demonstration of vortex shedding in computational and in vitro monolayer experiments.20  
Insufficient wavefront curvature combined with source-sink mismatch created by specific 
anatomic heterogeneities leads to wave break, vortex shedding, and the formation of rotating 
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spiral waves (Figure 1.7),21 also known as rotors, which are important contributors to both 
atrial and ventricular fibrillation.22,23   
 
Figure 1.7 Vortex shedding when the radius of curvature R fails to exceed the critical 
curvature for detachment RCr.21 
Similar to anatomic reentry, destruction of the wavefront through collision with another 
wavefront or a tissue boundary will result in reentry termination (Figure 1.8).24  As the 
source of the spiral wave is the rotor, the termination of functional reentry can also be 
accomplished through elimination of the rotor, either through the influence of another wave 
(Figure 1.9),24 through collision with an existing boundary (Figure 1.9B),25 or through 










Figure 1.9 Reentry termination in isolated canine atrial tissue through core excitation24 
 
Figure 1.10 Reentry termination in neonatal rat atrial myocyte culture  
 (A) Phase singularity-boundary collision and  (B) phase singularity-phase singularity 
collision secondary to light exposure of channelrhodopsin-expressing substrate.25 
1.4 Limits to our understanding of reentry 
Despite the undeniable progress over the past century in our understanding of reentrant 
activity, clinical progress in the management of patients with reentrant arrhythmias has been 
limited.  Gaps continue to exist both in our understanding of the mechanisms underlying 
reentry, as well as in our ability to terminate and prevent reentrant activity.  I focus here on 
two specific areas of interest, with significant clinical implications and which are 
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conceptually linked by an emphasis on the intrinsically spatiotemporal nature of reentrant 
activity: 1) what is the impact of substrate heterogeneity on the initiation, maintenance, and 
termination of reentry, and 2) how do we best manage reentrant activity? 
1.4.1 The impact of substrate geometry on re-entrant activity 
As discussed, the importance of conduction blocks and substrate heterogeneity has been 
recognized both conceptually and experimentally in our understanding of reentrant activity 
since the very first publications on the topic.  We know that anatomic heterogeneity is 
responsible for phenomena such as spiral wave initiation, termination, and maintenance, as 
functional reentry can convert to anatomic reentry when rotors encounter anatomic 
heterogeneities of the appropriate size.26,27  However, our understanding is fairly rudimentary, 
with an emphasis on simple examples such as circles or lines.  We have not yet reached the 
stage where we are able to utilize our insights for clinical application. 
One area of interest is the prediction of arrhythmia risk for specific scar patterns. One of the 
most recent publications in this area was the recently completed GAUDI-CRT study, which 
demonstrated the predictive value of scar heterogeneity, quantified as border zone mass on 
contrast-enhanced cardiac magnetic resonance imaging, for sudden cardiac death risk 
stratification in post-MI patients (Figure 1.11).28  Its results complement previous studies, 
which showed similar results.29–33  However, while promising, current studies say nothing 




Figure 1.11 Contrast-enhanced cardiac magnetic resonance images segmented into scar 
(red), border zone (green), and healthy tissue (purple) based on signal intensity for the 
GAUDI-CRT study28 
The ability to predict arrhythmogenicity as a function of scar shape and structure is 
particularly relevant in the context of catheter ablation.  Catheter ablation is a technique 
whereby electrophysiologists use a catheter to create scar tissue in the heart as a treatment for 
specific arrhythmias.  It is commonly used with success for ablation of accessory pathways in 
conditions such as Wolff-Parkinson White (WPW) Syndrome.17 Catheter ablation can also be 
used for the treatment of ventricular tachycardias in the context of myocardial infarction, 
where it is used to ablate narrow isthmuses in the scar border zone.  However, the success 
rate is much lower than that for WPW, and attempts to better stratify ablation candidates are 
ongoing.34  We are again limited by our inability to correctly predict arrhythmia risk as a 
function of scar, particularly with respect to how modifications of scar geometry can 
ameliorate that risk.  This is also true in the use of catheter ablation in the treatment of 
chronic atrial fibrillation, which is the most prevalent arrhythmia, and significantly increases 
the patient’s risk of suffering a stroke.  Here, catheter ablation is successfully used to isolate 
the pulmonary veins, which are the primary source of ectopic beats, but its success rate in 
atrial fibrillation that is refractory to pulmonary vein isolation is quite poor.35,36 
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Moreover, conduction blocks are only the most obvious manifestation of spatial 
heterogeneity in cardiac tissue.  Ventricular dyssynchrony is an important risk factor for 
death and cardiac remodeling following a myocardial infarction, and is associated with mitral 
regurgitation,37 while spatially heterogeneous action potential duration restitution and 
repolarization dispersion is linked with ventricular fibrillation, monomorphic ventricular 
tachycardia, and torsades de points.38–43  Islands of midmyocardial cells are also linked to the 
development of torsades de pointes in long-QT syndrome.44  Atrial fibrillation is associated 
with changes cardiac connectivity.45  These isolated observations require further systematic 
study to develop a proper theory for cardiac behavior as a function of substrate geometry. 
1.4.2 Methods to terminate reentry 
Treatment of reentrant arrhythmias relies on two main treatment modalities. Pharmacological 
treatment globally modifies substrate electrophysiology, with mixed results depending on the 
type of arrhythmia.46  For instance, pharmacological treatment for atrial tachyarrhythmias are 
often pro-arrhythmogenic in the ventricles, though there are now efforts to develop drugs that 
specifically target the atria.47  In contrast to pharmacological treatment, external pacing is 
typically applied at a few select locations.48,49  The MINERVA trial conducted in 2014 
directly compared DDDRP vs DDDRP + MVP (DDDRP = atrial preventive pacing, atrial 
antitachycardia pacing, MVP = managed ventricular pacing).  These algorithms are some of 
the most advanced algorithms in use, and yet they still only featured thze use of two leads: 
one in the atrium and one in the ventricle.  Studies using multiple stimulation sites per 
chamber for various indications are still relatively infrequent, and there is little mechanistic 
insight in the choice of stimulation site.50 
In spite of our best efforts, refractory arrhythmias persist in the face of optimal therapy.  
Conceptually, it appears that this can at least partially be attributed to the spatial simplicity of 
our available control schemes: either global pharmacological changes, or local pacing at a 
small handful of sites. The spatially heterogeneous pathologies mentioned in section 1.4.1 
demand spatially targeted solutions.  The only treatment that currently meets this definition is 
targeted catheter ablation for refractory arrhythmias,35,36,51 which remains limited in scope 
and development as previously discussed.  However, with the advent of technology such as 
flexible electrode arrays that could potentially provide hundreds of pacing locations,52 
optimization of spatially extended control schemes is a promising direction for research. 
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1.5 Computational insights 
Attempts to better understand 1) the interaction between substrate heterogeneity and reentrant 
activity, and 2) how to best terminate reentry, are currently best approached using 
computational methods.  For instance, a recent computational paper predicted a fractal-like 
pattern of the system’s dynamic steady state (quiescent, single reentrant circuit, disorganized 
chaos) as a function of obstacle location in a cardiac monolayer, with minute changes in 
obstacle placement leading to dramatic differences in the behavior of the system (Figure 
1.12).53  While the exact pattern is an artifact of the parameters of the computational 
experiment (as can be deduced by the lack of symmetry), the existence of bifurcations in 
system behavior sensitive to initial conditions is expected in nonlinear systems like the 
heart.20,54–56 
 
Figure 1.12 Fractal-like dependence of system response as a function of obstacle 
location.53 
A 40mm x 40mm obstacle was placed in every location, and the resulting behavior was 
characterized.  Squares represent behavior when the bottom-left corner of the obstacle was 
placed in that location: white is quiescence, black is a single rotating spiral, and gray is 
disorganized chaos.  The boundary between the black and white regions exhibits a fractal-like 
pattern with qualitative changes in behavior for minute changes in initial conditions.  This is 
characteristic for nonlinear, chaotic systems. 
Computational studies have also identified a number of promising control schemes, such as 
grids and traveling waves (Figure 1.13).53,57–59 Similarly, they have also been used to 
hypothesize mechanisms for arrhythmia termination through the modification of substrate 
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geometry via catheter ablation.60  Some studies have even looked at the robustness of theses 
spatiotemporal control schemes in the context of anatomic obstacles.61  However, these 
results require validation in biological systems with similar spatiotemporal resolution and 
throughput. 
 
Figure 1.13 Computational simulation of a traveling wave created by an array of 
electrodes.  Electrodes are distance d apart.  The traveling wave moves with speed v.  
The speed of conduction in the simulated tissue is c.62 
1.6 Limitations in current biological systems 
Unfortunately, biological systems are much more difficult to manipulate than computational 
models. Traditional methods for anatomic manipulation of tissues include manual excision or 
injury,20 3D printing,63 micropatterning,64 and reliance on stochastic processes.65,66 These 
methods are logistically involved, requiring hardware fabrication and the creation of new 
tissue samples for every iteration, and are technically limited in their precision.  
Consequently, large-scale experiments along the lines of the one shown in Figure 1.12 have 
not been attempted in biological substrates. 
Similarly, spatiotemporal control is only achievable by coupling the above with the laborious 
process of creating custom electrode arrays through photolithography, or the manual 
placement of electrodes.  As a result, the only algorithms that have been studied in biological 
systems are local pacing algorithms at a handful of electrodes,67 which constitutes a small 
corner of the experimental space.  
1.7 Summary 
In summary, while our understanding of reentry has greatly progressed over the past century, 
there are still significant gaps in our mechanistic understanding of how reentry is initiated, 
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maintained, and terminated, particularly in the context of anatomic heterogeneities.  One of 
the factors holding back progress is our inability to easily translate hypotheses that are 
generated in computational models to biological systems.  Further progress in this area would 
therefore be accelerated by the development of high-throughput biological systems that 
would allow us to 1) systematically characterize reentry as a function of substrate geometry, 
and 2) rapidly prototype novel control schemes. 
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2 INNOVATION, APPROACH, AND 
AIMS 
2.1 Innovation 
A number of recent advances in light-sensitive proteins and stem cell biology can now be 
combined with patterned illumination to enable precise spatiotemporal sensing and actuation 
of cellular membrane potential using optical systems. 
2.1.1 Optogenetics 
Optogenetics can be described as light-based actuation through genetic engineering. Light-
sensitive ion channels such as channelrhodopsin (Figure 2.1)68 or anion channelrhodopsin 
allow optical excitation/inhibition of excitable cells such as cardiomyocytes or neurons. The 
precise spatiotemporal control enabled by optogenetics makes it promising for in vitro 
applications in tissue engineering.  In comparison with electrical stimulation, optogenetic 
stimulation has some interesting properties as it allows us to: (i) target specific cell types, (ii) 
both excite and inhibit targeted cells, and (iii) take advantage of miniaturized projectors to 
easily achieve high-resolution spatiotemporal control of excitable tissues in vitro.69  The 
number of proteins available for optical sensing and actuation continues to increase as well, 
supporting both novel mechanisms of action as well as spectrally differentiated wavelengths 




Figure 2.1 Channelrhodopsin68 
2.1.2 Human induced pluripotent stem cells 
On the biological side, the development of human induced pluripotent stem cell (hiPSC) 
technology allows for the generation of multiple cell types from the same cell line.75–78 This 
property is most commonly used to facilitate the study of genetic diseases through the use of 
patient-derived cell lines,79,80 but also lends itself to the development and use of transgenic 
stem cell lines through genetic engineering.  These stem cell also lines serve as an unlimited 
source of human cells that are not readily available, such as human induced pluripotent stem 
cell-derived cardiomyocytes (hiPS-CMs).81  For these reasons, hiPSCs and their 
differentiation products have been rapidly adopted for in vitro studies. 
2.1.3 Patterned illumination and high-speed optical mapping 
Finally, advanced optical systems are available for imaging and patterned illumination of 
biological systems with high spatiotemporal resolution.69,82  In 2009, Fairchild Imaging, 
Andor Technology, and PCO together developed scientific CMOS (sCMOS) sensors 
characterized by high frame rates with high spatial resolution (100fps with full-frame 
resolution of 2048 x 2048 pixels), high quantum efficiency (>84%), and low noise.  These 
cameras are ideal for optical mapping, which requires high speeds and spatial resolution 




In the space of patterned illumination, there are a number of sptial light modulating 
technologies now available.  For 2D projection, one of the most commonly used technologies 
are the digital micromirror devices (DMD) invented at Texas Instruments.  Initially 
conceived as a deformable mirror device in 1977, the device evolved to its current, bistable 
switching form in 1987 (Figure 2.2).84 It was finally commercialized in 1996 under the 
auspices of Digital Light ProcessingTM technology, and has since taken over a large portion 
of the projection display market.84  This technology is uniquely suited for patterned 
illumination in the context of cardiac electrical activity, with modern DMDs offering 
millisecond temporal precision and greater than HD pixel counts. 
 
Figure 2.2 Digital Micromirror Device84 
2.2 Hypothesis 
We hypothesized that we could develop a novel in vitro platform using optogenetic methods 
for the characterization of reentrant activity as a function of substrate heterogeneity, and the 
validation of novel control schemes. 
We created stable hiPSC lines expressing channelrhodopsin (ChR2), a cation channel that 
depolarizes the membrane in response to ~470nm light,85 or anion channelrhodopsin 2 
(GtACR2), an anion channel that hyperpolarizes the membrane in response to ~470nm 
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light.71  These light-sensitive cardiac tissues will enable dose-dependent, spatially 
heterogeneous control of cell excitation through the use of patterned light.  The light patterns 
will be created by integrating a projector into existing optical mapping systems, allowing for 
simultaneous imaging and stimulation. The end-result will be a system capable of controlling 
the spatiotemporal propagation of waves through cardiac tissue in real time (Figure 2.3).  
This approach would meet the experimental need described in section 1.7. 
 
Figure 2.3 Graphical Abstract.  Patterned illumination of optogenetic proteins allows 
for high-resolution spatiotemporal control of cardiac tissue. 
Channelrhodopsin (ChR2) and anion channelrhodopsin 2 (GtACR2) are cation/anion 
channels that open in response to blue light, leading to membrane 
depolarization/hyperpolarization.  The use of a projector in combination with these 
optogenetic proteins allows for easy, spatially extended, high-resolution control of transgenic 
cardiac tissue. We use ChR2 to test control algorithms, and use GtACR2 to model conduction 
blocks. 
2.3 Relationship with control theory 
Control algorithms for dynamically changing systems require closed-loop feedback, where 
sensors detect changes in the system, and that information is used to modify the actuation that 
the system receives in real-time. Closed-loop control where sensing information is routed 
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back into the control algorithm is superior to open-loop systems where feedback is not used. 
Abstractly, our approach can be conceptualized as the development of a control system with 
all-optical actuation and sensing for high-throughput in vitro modelling (Figure 2.4). 
 
Figure 2.4 All-optical actuation and sensing control system 
2.4 Experimental approach 
We developed human stem cell lines expressing channelrhodopsin, a nonspecific cation 
channel that depolarizes the membrane in response to ~470nm light,85 and anion 
channelrhodopsin, an anion channel that hyperpolarizes the membrane in response to ~470nm 
light.86 Cardiomyocyte monolayers differentiated from these transgenic cell lines formed the 
substrate for patterned illumination and imaging.  A projector was integrated into existing 
optical mapping systems, allowing for simultaneous imaging and stimulation. We then use 
this platform to systematically evaluate the efficacy of novel spatiotemporal control 
algorithms for arrhythmia control and to characterize the interaction between arrhythmias and 
conduction blocks. 
2.4.1 Development of transgenic hiPSC lines 
hiPSCs were transduced with lentivirus to express either ChR2 or GtACR2. YFP 
fluorescence following FACS demonstrates successful transduction of hiPSCs and 
transmembrane localization of the ChR2-YFP (Figure 2.5A) and GtACR2-YFP fusion 
proteins.  Transgenic hiPSCs stained positive for Nanog, Sox2, and Oct3/4, confirming 
maintenance of pluripotency (Figure 2.5A). 
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2.4.2 Differentiation of light-sensitive cardiomyocytes 
Transgenic hiPSCs were subsequently differentiated into light-responsive cardiomyocytes 81 
(Figure 2.5B).  Spot illumination of ChR2-expressing cardiomyocytes with 470nm light 
enabled spatially targeted depolarization and subsequent radial propagation of contractile 
activity (Figure 2.5C), while GtACR2-expressing cardiomyocytes stopped contracting when 




Figure 2.5: Creation of an in vitro platform for spatiotemporal control of human 
cardiac tissue through optogenetics 
(A) Transmembrane localization of ChR2-eYFP fusion protein and maintenance of 
pluripotency markers in hiPSCs following transduction.  (B) Transgenic hiPS-CMs stain 
positive for α-actinin.  (C) Bright field imaging of ChR2-expressing hiPS-CM monolayers 
show single-spot illumination of the red square followed by radial propagation of contraction.  
Image processing is used to identify contractile motion (white pixels show motion). (D) 
GtACR2-expressing hiPS-CM monolayers cease contraction in response to illumination.  (E-
F) Diagram and solidworks rendering of the projector integrated into the optical mapping 
system. 
 
Figure 2.6 Spatiotemporal control of electrical activity through optogenetics. 
Patterned illumination allow us to generate arbitrary waveforms in ChR2-expressing 
hiPS-CM monolayers such as (A) colliding waves and (B) a cross.  Patterned 
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illumination allows us to generate arbitrary conduction blocks in GtACR2-expressing 
hiPS-CM monolayers such as (C) a square, and (D) the outline of a cat. 
2.4.3 Development of a platform for simultaneous patterned illumination and 
optical mapping 
In parallel, a projector was integrated into an optical mapping system for simultaneous 
patterned illumination and imaging (Figure 2.5E-F).  A number of dyes were tested for 
compatibility with our optogenetic proteins.  All optical mapping data was collected with the 
Cal-590 calcium dye, which was selected for its wavelength compatibility as well as for its 
stability for long duration imaging.  Custom MATLAB software was developed to analyze 
the resulting videos.    
2.4.4 Platform capabilities 
Arbitrary illumination patterns such as a cross (Figure 2.6A) or two rectangles on opposite 
sides of the imaging area (Figure 2.6B) initiated wavefronts in ChR2-expressing monolayers 
that propagated into neighboring regions. In GtACR2-expressing monolayers, conduction 
was blocked in illuminated regions (Figure 2.6C), with more complex conduction blocks 
leading to more complex waveforms (Figure 2.6D).  
2.5 Aims 
The following aims were selected to demonstrate the breadth of research questions that can 
be answered using our system.  To characterize the impact of anatomic defects with high 
precision, we utilized anion channelrhodopsin to generate light-inscribed conduction blocks, 
and dynamically modulate them to manipulate spiral waves in novel ways. We then tested 
spatially extended control schemes in heterogeneous monolayers of channelrhodopsin-
expressing cardiomyocytes. Finally, we used hiPSCs from long QT patients to study the 
impact of prolonged action potential durations on spiral wave termination efficiency.87,88 
 
Aim 1: Characterizing the interaction between reentry and conduction blocks 
 
Aim 2: Spatiotemporal control of heterogeneous substrates 
 




3 AIM 1: CHARACTERIZING THE 
INTERACTION BETWEEN 
REENTRY AND CONDUCTION 
BLOCKS 
3.1 Rationale 
As previously discussed, reentry is more prevalent in the context of anatomic heterogeneities 
that lead to source-sink mismatches, wave break, and vortex shedding.  The goals of this 
section are therefore two-fold.  The first is to validate the use of light-inscribed conduction 
blocks to study the impact of anatomic heterogeneities on reentry.  The second is to 
demonstrate its utility by addressing outstanding questions.  All experiments involve the use 
of patterned illumination of GtACR2-expressing hiPS-CM monolayers to generate light-





3.2.1 Light-inscribed conduction blocks initiate and maintain reentry 
To validate the use of light-inscribed conduction blocks, we sought to show that the 
interaction between propagating waves with light-inscribed conduction blocks could 
functionally replicate important behaviors attributed to anatomic heterogeneities. 
3.2.1.1 Light-inscribed conduction blocks initiate functional reentry through vortex shedding 
Anatomic heterogeneities are an important factor in the initiation of reentry through 
behaviors such as vortex shedding, whereby traveling waves interact with static conduction 
blocks to generate spiral waves.20 Our light-inscribed conduction blocks recapitulate this 
behaviour (Figure 3.1A), and can thus be used to study the physiologic phenomena 
underlying these interactions. In comparison with a rectangular block (Figure 2.6C), the 
wave must make a sharper turn to wrap completely around the arm of the backwards “C” 
used here while remaining adherent to the obstacle, thereby increasing the propensity for 
detachment and spiral wave formation.20 
3.2.1.2 Functional reentry converts to anatomic reentry upon interaction with conduction 
blocks of the appropriate size 
As our system allows us to dynamically modulate our conduction blocks, we use this 
capability to explore other phenomenon.  For instance, slowly growing the size of our 
conduction blocks allow us to capture pre-existing spiral waves that are freely rotating in the 
monolayer, such that they adhere to the conduction block and start rotating around the 
conduction block (Figure 3.1B).  It has been shown computationally that spiral waves are 
attracted to localized heterogeneity,89 and experiments have also demonstrated the size-
dependent capture effect shown here.26 
3.2.2 Reentrant circuits pinned to light-inscribed conduction blocks can be 
moved 
Furthermore, the spiral waves remain pinned to the conduction block even when the 
conduction block is moved (Figure 3.1C), allowing us to freely relocate spiral waves. This 
phenomenon can also be observed across large distances, such as when moving the 
monolayer itself.  The ability to relocate spiral waves to desired locations greatly increases 
our capabilities for experiments such as the systematic study of spiral waves and their 
interaction with anatomic heterogeneities and each other.27,90  It could also be used as a 
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means of controlled defibrillation through phase singularity-boundary collision, or phase 




Figure 3.1 Dynamic light-controlled conduction blocks.   
(A) Vortex shedding and the formation of a spiral wave.  (B) Freely rotating spiral waves pin 
to an expanding light-generated conduction block.  (C) A spiral wave is isolated inside a box 
inscribed by light, and pinned to a light-generated conduction block.  The conduction block is 
then moved, first to the right, and then to the left, and the spiral wave follows.  (D)  A spiral 
wave is isolated inside a gradually shrinking circle until it dissipates.  (E) Distribution of 
circle radii when the spiral wave dissipates (n = 9, mean +/- s.e.m. (light gray) and s.d. (dark 
gray)). 
3.2.3 Gradually shrinking the electrically active substrate in the neighbourhood 
of functional reentry results in reentry termination below a critical size 
Finally, we note that we are able to isolate spiral waves by using light to inscribe conduction 
blocks in a border around the phase singularity (Figure 3.1C-D), effectively isolating its 
domain from the rest of the monolayer.  We realized that this would allow us to measure the 
minimum area of tissue capable of sustaining reentry, which is of interest in relation to the 
critical mass hypothesis 92–95.  We hypothesized that we could slowly shrink the borders 
around the phase singularity, and measure the radius of the resulting isolated monolayer when 
it dissipated (Figure 3.1D).  We found that the average monolayer radius when the spiral 
wave dispersed was 0.79mm, with a minimum radius of 0.65mm (Figure 3.1E).  We suggest 
that the corresponding minimum area of 1.33mm2 is close to the smallest hiPS-CM 
monolayer that can support sustained reentry.  This number is much smaller than the smallest 
area demonstrated for in vivo/ex vivo tissue, likely reflecting the lower conduction velocities 
in the hiPS-CM monolayer model as slower propagation speeds/shorter wavelengths enable 
reentry in smaller areas of tissue 94,96,97.   
3.3 Discussion 
In terms of functional validation, we have demonstrated that the illuminated regions exhibit 
classic behaviors associated with conduction blocks such as the initiation, maintenance, and 
termination of reentry.  
Mechanistically, there is some additional nuance to the interpretation of the results.  
Technically, the boundary conditions for light-inscribed blocks involving the pinning of the 
29 
 
membrane voltage to a hyperpolarized stated, which decreases the source-sink ratio in the 
neighbourhood of the conduction block.  This is different from conduction blocks with no-
flux boundary conditions such as collagen scar or anatomic structures, which exert no effect 
on the source-sink ratio beyond the geometric considerations.  Therefore, light-inscribed 
blocks should likely be considered more similar to anatomic heterogeneities involving cells 
such as damaged cardiomyocytes or fibroblasts that similarly lower the source-sink ratio in 
their neighbourhood.  Clinically, the peri-infarct zone often includes a large proportion of 
nonmyocytes that couple with myocytes in the neighboring healthy tissue.98,99 As such, the 
correct source-sink relationship at the boundary to model scar tissue likely varies on a case-
by-case basis.  
Further complicating the picture is that the effect of no-flux conduction blocks is size-
dependent.  As the size of the conduction block shrinks, anatomic reentry gradually 
transitions to functional reentry.26  As previously described, functional reentry is 
characterized by a gradient of gradually decreasing source-sink ratio that terminates when 
that ratio reaches a critical point, leaving a nonexcited but excitable core region.  Again, this 
is similar to what we have with light-inscribed conduction blocks.  Finally, the effect of the 
boundary condition diminishes in importance away from the boundary, so the spatial scale of 
the experiment should be taken into account when determining its importance. 
In terms of utility, it should be obvious that light-inscribed conduction blocks offer higher 
throughput than techniques which involve irreversible modification of the substrate such as 
manual excision.  Further, the ability to dynamically alter our patterns allows us to perform 
experiments not previously possible, such as the relocation of spiral waves.  Finally, the 
critical mass experiments demonstrate the increased technical capability offered by this 








As previously discussed, in addition to the use of our platform to model conduction blocks, 
the other goal was to test spatially extended control schemes based on the hypothesis that this 
would be better than local pacing.  Therefore, we would like to demonstrate qualitative 
improvements in our ability to control electrical activity through the use of spatially extended 
control schemes in comparison with local pacing using our platform. We hypothesized that 
the differences between local pacing and spatially extended control schemes would best be 
shown through the use of spatially heterogeneous substrates. 
4.2 Results 
4.2.1 Heterogeneous monolayers demonstrate disorganized waveforms 
To generate a spatially heterogeneous substrate, ChR2-expressing hiPS-CMs were re-plated 
into heterogeneous clumps of cardiomyocytes, which were then connected by proliferating 




4.2.2 Qualitative restoration of planar wave propagation can be accomplished 
using dynamic pacing 
Two types of control pulses were compared to restore traveling waves of electrical activity: 
(i) static pacing of the right half-plane, and (ii) dynamic traveling waves moving from right to 
left. Each control pulse was preceded by a full-field pulse to uniformly depolarize the 
monolayer. Static pacing of the right half-plane failed to restore the normal propagation of 
traveling waves through this substrate (Figure 4.1B).  In contrast, the projection of 
propagating waves of light restored the normal propagation of cardiomyocyte depolarization 
(Figure 4.1C).  This shows that the use of spatially extended control schemes can be 
qualitatively better than localized pacing schemes. 
 
Figure 4.1 Dynamic light-controlled depolarization in heterogeneous monolayers 
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(A) Heterogeneous monolayers exhibit disorganized conduction. (B)  Static pacing of the 
right half-plane failed to restore the orderly propagation of electrical activity. (C) 
Projection of traveling waves rescues orderly propagation of electrical activity as a 
planar wavefront.  (D) The speed of imaged waves (blue bars) closely matched the speed 
of projected waves (red bars). (n >= 5 for each group, mean ± 95% confidence intervals, 
p < 0.05, two-sample t-test). 
4.2.3 Quantitative control of wave propagation speed 
Over a wide range of speeds, the speed of the imaged wave closely matches the speed of the 
projected wave (Figure 4.1D).  This shows that our system is able to exert quantitative 
control over wave propagation in the underlying substrate. 
4.3 Discussion 
This study shows that in cases of anatomic heterogeneity, spatially extended control 
algorithms can succeed in controlling waveforms in cases where local pacing fails.  This 
corroborates both computational61 and clinical studies,50 which show that an increased 
number of control points can achieve better control of electrical activity, and supports the 
further development of spatiotemporal control schemes.  Further, based on these results, our 
platform appears to be suitable for high-throughput in vitro testing of control schemes. 
One caveat to the results shown here is that our heterogeneous substrate does not exhibit 
classical reentry, likely due to the specific ratio of cardiomyocytes to fibroblasts and their 
seeding locations.  Adopting doubly transduced cell lines expressing both depolarizing and 
hyperpolarizing optogenetic channels would allow us to simultaneously control both substrate 






5 AIM 3: DEFIBRILLATING 
SPIRAL WAVES IN LQT8 
 
5.1 Rationale 
To further demonstrate the utility of hiPSCs in this system, patient-derived hiPSCs were used 
to model LQT8, where L-type calcium channel mutations interfere with channel inactivation, 
resulting in abnormal calcium overload and prolonged action potential.87 The long-QT 
syndromes are important for a number of reasons. Clinically, untreated patients have a 
mortality rate of 21% within 1 year of the first syncopal episode, a statistic that decreases to 
1% over 15 years with optimal management.5 The strong genotype-phenotype correlation and 
wide range of mutations also makes LQTS one of the best models for studying mechanisms 
that predispose patients to arrhythmias and sudden cardiac death.  We would like to use our 





5.2.1 A disease model of LQT8 using patient-derived hiPSCs. 
Patient cell lines were transduced with ChR2, and differentiated into cardiomyocytes with 
extended action potential durations.  Spiral waves spontaneously formed in the resulting 
monolayers. 
 
Figure 5.1 Spiral wave defibrillation in Timothy Syndrome monolayers.   
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 (A) Successful defibrillation sequence in monolayer with calcium transient duration of 
475ms.  (B) Failed defibrillation sequence in monolayer with calcium transient duration of 
1300ms. (C) Successful defibrillation sequence in monolayer with on-target defibrillation 
pulse. (D) Failed defibrillation sequence in monolayer with off-target defibrillation pulse.  
(E) Quantification of defibrillation results as a function of calcium transient duration and 
targeting (n = 189, mean +/- first and third quartile (box) and whole range (brackets), p = 
2.267e-07 < 0.05, two-sample t-test). 
5.2.2 Dependence of defibrillation success rate on calcium transient duration 
We found that spiral waves with short calcium transients were easy to destabilize using 100-
ms duration pulses of light and relatively small illumination areas (Figure 5.1A).  However, 
spiral waves with long calcium transients were more difficult to destabilize, even using larger 
illumination areas (Figure 5.1B).  
5.2.3 Dependence of defibrillation success rate on location of defibrillatory 
impulse 
We also explored the relationship between illumination pattern and spiral wave defibrillation.  
An illustrative example shows that illumination of the spiral wave core for a spiral wave 
pinned to anatomic heterogeneities leads to successful unpinning (Figure 5.1C), whereas 
failure to illuminate the spiral wave core for a second spiral pinned to the same location leads 
to failed defibrillation (Figure 5.1D).   
5.2.4 Quantification 
To summarize these findings, over the course of 189 defibrillation attempts (117 attempts 
with on-target defibrillation, 72 attempts with off-target defibrillation) using a variety of 
illumination geometries, we can see that there were no instances of successful defibrillation 
when the illuminated region missed the phase singularity (Figure 5.1E).  Further, the average 
calcium transient duration for successful defibrillation attempts was significantly shorter than 
that for failed defibrillation attempts (Figure 5.1E), indicating that the increase in action 
potential duration also increases the resistance of individual rotors to termination secondary 





While these results seem biologically plausible given the increased arrhythmogenicity 
associated with the long-QT syndromes, it contrasts with a previous study in Langendorff-
perfused rat hearts where pharmacologically shortened action potential durations prevented 
arrhythmia termination following a single 1s long optogenetic impulse.100 Further studies will 
be required to tease apart the differences in geometry, electrophysiology, and defibrillation 




6 DISCUSSION AND FUTURE 
WORK 
6.1 Technical advances 
The work described here demonstrates a number of technical advances compared to the 
existing literature.  In particular, this is the first study to generate stable optogenetic hiPSC 
lines, to look at patterned illumination in optogenetic human cardiac substrates, and to use 
anion channel rhodopsins to generate light-inscribed conduction blocks in cardiac tissue. 
6.1.1 Patterned illumination of optogenetic human cardiac substrates 
In the intervening time since this project was conceived, patterned illumination of 
optogenetic substrates was used for the in vitro control of electrical activity in animal cardiac 
cells and tissues.69,101,102 However, despite the successful genetic engineering of hiPS-CMs to 
express channelrhodopsin following differentiation, those studies did not extend to the 
application of patterned illumination.103 This is therefore the first instance of patterned 
illumination of optogenetic human cardiac substrates. The use of stable transgenic human 
stem cell lines allows for experimentation in human models with human electrophysiology, 
and also obviates the need for repeated genetic modification for each experiment using 
primary cells. 
The generation of stable optogenetic hiPSC lines and their differentiation into 
cardiomyocytes allowed for consistent experimentation in human substrates with human 
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electrophysiology, and also obviates the need for repeated genetic modification for each 
experiment using primary cells.  To further illustrate the utility of hiPSC technology, we 
additionally conducted studies using patient-specific cells, demonstrating the potential for 
personalized genetic disease models. 
6.1.2 Patterned illumination of hyperpolarizing optogenetic channels for light-
inscribed conduction blocks 
In contrast to previous reports in animal substrates,102 continuous illumination of ChR2-
expressing hiPS-CMs rarely generated conduction blocks. Further, the initial illumination of 
ChR2-expressing cardiomyocytes generated a depolarization wavefront that disrupted the 
existing waveforms, a known phenomenon that limits the applicability of this technique. As 
such, the introduction of hyperpolarizing optogenetic channels to generate light-inscribed 
conduction blocks represents a major technical advance in our ability to generate spatially 
heterogeneous substrates.  The ability to dynamically manipulate conduction blocks in real-
time represents a novel and powerful tool for the study of spiral wave dynamics in spatially 
heterogeneous substrates, particularly through the ability to reproducibly relocate spiral 
waves to desired locations.   
6.2 Scientific findings 
New scientific findings described in this dissertation include the ability to model anatomic 
heterogeneities using light-inscribed conduction blocks, the superiority of spatially extended 
control schemes to control arrhythmias in spatially heterogeneous models, and the 
detrimental impact of prolonged APD on spiral wave defibrillation efficiency using single 
pulses of light. 
6.2.1 Light-inscribed conduction blocks using hyperpolarizing optogenetic 
proteins recapitulate key behaviors of anatomic heterogeneities 
The coupling of patterned illumination and hyperpolarizing optogenetic tools allowed us to 
generate dynamic, light-inscribed conduction blocks, and to observe spiral wave formation, 
pinning, and termination at a critical minimum area.  These behaviors are consistent with the 
effects of anatomic heterogeneities generated using other means, and confirm the utility of 
our system in studying these interactions.   
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6.2.2 Important parameters in our system are related to the wavelength 
The critical minimum area capable of supporting reentry in hiPS-CM monolayers has not 
been previously measured. The value that we measured was substantially smaller than that 
found in native tissue. Similarly, the obstacles to which spiral waves adhered in our system 
were also quite small. Both parameters are closely related to the conduction velocity and 
reentry wavelength,26 and the small values found in our system are consistent with the 
decreased conduction velocities and wavelengths found in hiPS-CM monolayer preparations. 
6.2.3 Spatially extended control schemes are superior to local pacing schemes in 
spatially heterogeneous models 
Using monolayers of optogenetic human cardiomyocytes, we showed that spatially extended 
control schemes are necessary to achieve control in heterogeneous substrates, in line with 
computational results.61  Clinically, this suggests that current pacing methods that rely on a 
small handful of electrodes are likely insufficient to control the propagation of electrical 
activity in patients with extensive regions of anatomic heterogeneity.  The substrate used here 
is reminiscent of the peri-infarct zone following myocardial infarctions, which is 
characterized by bundles of viable cardiomyocytes separated by scar tissue.  In patients with 
scar tissue, it was shown that the use of multiple point pacing led to better outcomes 
compared to single point pacing.50  Our results are complementary, and together support the 
continued development of flexible electronics, which could theoretically offer hundreds of 
control points.52 
6.2.4 Prolonged action potential durations associated with long QT syndrome 
decrease defibrillation efficiency 
Our studies of monolayers derived from patients with long QT syndrome showed that the 
prolonged action potential durations in these patients decrease the success rate of spiral wave 
termination by exogenous pacing. In combination with previous results,100 this suggests that 
the relationship between action potential duration and ease of spiral wave termination is 
nonlinear in nature. It was previously shown that pharmacological lengthening of the action 
potential duration decreased the average number of rotors.91  The decrease in the average 
number of rotors previously documented means that each individual rotor exerts its influence 
over a larger domain, thereby decreasing the probability of rotor termination through 
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collision with wavefronts generated by neighboring rotors and potentially accounting for part 
of the observed increase in rotor stability. 
6.3 Limitations 
6.3.1 Shortcomings of the hiPS-CM monolayer model 
There are a number of shortcomings for the hiPS-CM monolayer model when it comes to 
modelling real human cardiac tissue, primarily related to maturation.  The immaturity of 
these cells means that important electrophysiological properties such as conduction velocity 
are much lower in monolayers.  These deficiencies are currently being addressed in in vitro 
tissue engineered models.104 
6.3.2 Characterization of light-inscribed conduction blocks 
An additional aspect that needs further characterization is the nature of light-inscribed 
conduction blocks, and how similar they are to conduction blocks caused by myocardial 
infarction.  In particular, the light-activated anion channels drive down the membrane 
potential whereas myocardial infarction is traditionally thought to create no-flux boundary 
conditions.  However, recent studies have challenged this notion, and have suggested that 
heterocellular electrotonic coupling occurs between nonmyocytes and cardiomyocytes 
following scar formation.99  A direct comparison is warranted to further clarify the suitability 
of light-inscribed conduction blocks as a model of infarction. 
6.4 Future directions: Bridging gaps in translation 
Our platform is located at the intersection of four rapidly innovating fields: computational 
modeling, cell and tissue engineering, optogenetics, and personalized medicine. This platform 
draws on a number of technologies from these disciplines to evaluate hypotheses, and bridge 
the gap between computational models and clinical translation in the field of 




Figure 6.1: Contextualizing our platform 
 
With appropriate validation, the ability to generate light-inscribed conduction blocks that 
recapitulate the interaction between anatomic heterogeneities and spiral wave behavior opens 
the door for the high-throughput testing and prediction of arrhythmia risk as a function of 
patient scar geometry, as well as the performance of virtual catheter ablations.   
Further genetic engineering to create doubly transduced cell lines and mouse models would 
allow for additional exploration. Clinical mapping data could be used in conjunction with 
computational models and our platform to determine the optimal electrode placement and 




Figure 6.2 Modeling patient scar tissue and defibrillation strategies 
6.5 Concluding thoughts 
In summary, the optogenetic approach described here allows for precise spatiotemporal 
modulation of electrical activity in human cardiac tissue, with direct translation to clinical 
applications. With advancements in cardiac tissue engineering and further genetic 
engineering to generate doubly transduced optogenetic cell lines, we foresee high-throughput 
optimization of electrode placement and defibrillation algorithms for personalized anatomic 
and functional defects. The combination of patterned conduction blocks, patient-derived 
cells, and spatially extended control schemes thus forms a basis for personalized disease 
models and interventions.  
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7 MATERIALS AND METHODS 
7.1 Stem cell culture 
Experiments on healthy stem cells were performed using C2a105 and WTC-11 (from the 
Bruce Conklin laboratory) hiPSCs .  Timothy Syndrome experiments were performed using 
T-3-5 hiPSCs.88  Stem cells were maintained in mTeSRTM1 (Stemcell Technologies #85850) 
+ 1% v/v penicillin/streptomycin (ThermoFisher Scientific #12430-047).  Media was 
changed daily for three to four days between passages.  For passaging, standard 6-well tissue 
culture plates were pre-coated for stem cell culture with 1mL/well of Matrigel (ThermoFisher 
Scientific #CB-40230) diluted in DMEM/F12 (ThermoFisher Scientific #11320-033) at a 
ratio of 1:80. Plates were stored at 4°C for up to two weeks before culture.  Prior to 
passaging, plates were incubated at room temperature for one to four hours.  Stem cells were 
dissociated by incubation with 0.5mM EDTA (ThermoFisher Scientific #15575-038) in PBS 
(ThermoFisher Scientific #21-040-CV)for five minutes followed by rigorous mechanical 
shearing with a P1000 pipette.  Stem cells were seeded at a ratio of 1:12 in mTeSRTM1 + 
2µM Y-27632 dihydrochloride (Tocris 1254) in 2mLs total volume per well. 
7.2 Lentiviral transduction 
Transgenic cell lines were created by infection of hiPSC lines with lentivirus.   For ChR2-
expressing cell lines, we used the commercially available pLenti-EF1a-hChR2(H134R)-
EYFP-WPRE (Addgene #20942, 106) plasmid.  For hyperpolarizing cell lines, the GtACR2 
sequence was cloned from a commercially available plasmid (pFUGW-hGtACR2-EYFP , 
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Addgene #67877, 71) into the pWPXL backbone (Addgene #12257) for subsequent 
transduction into hiPSCs.  The EF1α promoter was chosen to ensure expression of the ChR2-
YFP/GtACR2-YFP fusion proteins in both stem cells (for selection by FACS) and their 
differentiation products (for optical stimulation).  After infection, YFP+ cells were selected 
by FACS and expanded to create transgenic cell lines.  
Human embryonic kidney cells HEK-293FT (ThermoFisher Scientific # R700-07) grown in 
Dulbecco’s Modified Eagle Media (ThermoFisher Scientific #11965-092) supplemented with 
2% v/v of fetal bovine serum (FBS) (Atlanta Biologicals #S11150) and 1% v/v 
penicillin/streptomycin (ThermoFisher Scientific #12430-047) were transfected with 32.73 
µg of the target plasmid, 10.91 µg of viral envelope plasmid (pMD-gVSV-G) and 21.82 µg 
of packaging construct (pCMV ΔR 8.2) using polyethylenimine (Polysciences # 23966). 
After 60 hours supernatant was filtered through a 0.45 mm low protein-binding Steriflip-HV, 
(Millpore # SE1M003M00) and the viral particles were precipitated using Lenti-X 
Concentrator (Takara # 631231). Following transduction, YFP+ cells were selected by FACS 
and expanded. 
7.3 Cardiomyocyte differentiation 
Cardiomyocytes were differentiated following established protocols 107.  Briefly, 
differentiations were started when stem cells reached 70-90% confluence.  The basal media 
for the differentiation sequence was CDM3, consisting of RPMI-1640 (ThermoFisher 
Scientific #11875-093) + 500ug/mL albumin (ScienCell OsrHSA) + 213ug/mL ascorbic acid 
(Wako chemicals 321-44823).  On day 0, stem cells were incubated in CDM3 + 3-6uM CHIR 
(Tocris # 4423).  On day 2, media was changed to CDM3 + 2uM Wnt-C59 (Tocris #5148).  
On day 4, media was changed to CDM3 with no supplements.  Media was changed every two 
days afterwards.  Cardiomyocytes commenced spontaneous beating between days 8-12, 
whereupon media was switched to RPMI + B27 (ThermoFisher Scientific #17504-044) + 
213ug/mL ascorbic acid. 
7.4 Brightfield contractility analysis 
For movies S1 and S2, brightfield movies were processed to extract motion by subtracting 
every frame from a baseline frame to get a matrix of differences.  The absolute value of the 
difference was visualized as an intensity image to display side-by-side with the original frame 
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in the movies.  The amount of motion in each region of interest at any time point was 
calculated as the average absolute value of the difference matrix across the region of interest.  
This value was calculated for all time points to create the trace of contractile activity for each 
region of interest.  The light intensity trace was extracted from the video by finding the 
average intensity value across the illuminated region for each time point.  This value was 
thresholded to create a binary on/off trace to better represent the actual illumination sequence 
which was also a binary on/off sequence. 
7.5 Optical platform for simultaneous patterned illumination and 
optical mapping 
We selected the Andor Zyla 4.2 sCMOS camera for optical mapping due to its high 
spatiotemporal resolution (2048x2048 at 100fps), quantum efficiency, and signal-to-noise 
ratio at low light levels. The setup includes the camera, the tube lens (Edmund Optics #89-
606, #89-905, #86-835), the imaging objectives (standard Olympus microscope objectives at 
varying magnifications), the relay lens system and dichroic mirrors used to couple the 
projector/digital micromirror device (Texas Instruments DLPLCR4500EVM) and mercury 
lamp (Nikon Intensilight C-HGFI) to the main light path, and the excitation/emission filters 
for channelrhodopsin and the calcium dye.  This platform was used to simultaneously 
perform patterned illumination of optogenetic cardiac monolayers and high-speed optical 
mapping.  All experiments were performed with maximum illumination intesntiy, 
~1mW/mm2. 
7.6 Optical mapping 
The calcium dye Cal-590TM AM (AAT Bioquest #20510) was selected for its wavelength 
compatibility and its stability in long duration imaging.  Cells were incubated in 
cardiomyocyte media containing 2mM Cal-590TM AM with PowerLoadTM (Thermofisher 
Scientific #P10020) at 37C for one hour.  The incubation media was replaced with fresh 
cardiomyocyte media immediately prior to imaging. 
7.7 Optical mapping analysis 
Optical mapping analysis was performed using standard image processing techniques.  
Movies were preprocessed for optical mapping to reduce noise by spatial binning to a final 
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spatial resolution of 256x256 pixels, and by filtering every pixel with a low-pass frequency 
filter.  Temporal windows for activation mapping were selected based on the interval between 
successive depolarizations in the monolayer (determined by the pacing frequency for paced 
videos, or spontaneous depolarizations/spiral wave activity in unpaced videos).  Activation 
times were determined as either the time of maximum fluorescence intensity (Fmax) or the 
time of maximum rate in fluorescence increase (dF/dtmax).   
7.8 Light-inscribed conduction blocks (Figure 3.1) 
Movies to project were generated using either Matlab or powerpoint.  For experiments to 
study the initiation of spiral waves such as that shown in Figure 3.1A, regions with planar 
wave propagation were chosen for experimentation.  For experiments manipulating spiral 
waves such as those shown in Figure 3.1B-D, pre-existing spiral waves were identified in the 
monolayer.  The locations were manually centered, recording was commenced, and then the 
patterned illumination movies were started. 
7.9 Spiral wave radius calculations (Figure 3.1D-E) 
A rectangle with a hollow center circle was projected onto spiral waves in the monolayer.  
The radius of the hollow circle was gradually decreased until it disappeared.  The behavior of 
the spiral wave was observed until it disappeared.  The frame at which the spiral wave 
disappeared was manually selected in post-processing.  A circle was then fitted to the image 
of the hollow circle using Matlab to determine its radius in that instant. 
7.10 Creation of heterogeneous monolayers (Figure 4.1) 
To generate a spatially heterogeneous substrate, ChR2-expressing hiPS-CMs differentiated 
following the above protocol were incompletely dissociated with a combination of 
collagenase digestion (Worthington LS004176, 2mg/mL in HBSS) and mechanical shearing 
using P1000 pipettes.  Digestion times and amount of mechanical shearing were titrated on a 
well-by-well basis to achieve incomplete dissociation.   Digestion products were centrifuged 
at 170 rcf for five minutes.  Digestion products were resuspended in RPMI + B27 + 20% 
FBS, and then centrifuged again.  Digestion products were again resuspended in RPMI + B27 
+ 20% FBS and then seeded at multiple concentrations.  Wells for experimentation were 
chosen on the basis of heterogeneity.  Experiments were performed one week after seeding, at 
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which point the clumps of cardiomyocytes were connected by a sheet of proliferating 
supporting cells. 
7.11 Analysis of heterogeneous monolayers (Figure 4.1) 
For heterogeneous monolayers, we needed to segment out the cardiomyocytes from the 
intervening supporting cells.  Operating on the theory that cardiomyocytes and supporting 
cells have distinctly different fluorescent traces when imaged with calcium dyes, the intensity 
traces for each pixel were scored based on the fluorescence trace (e.g. maximum change in 
fluorescence) and automatically segmented into cardiomyocyte pixels vs. supporting cell 
pixels using k-means clustering or Otsu’s method.  This mask was used to select pixels for 
subsequent activation mapping.  Polynomial fitting was then used to interpolate the gaps 
between the cardiomyocytes to generate smooth wavefronts.  The gradient of this surface was 
calculated (dt/dDistance) and inverted to calculate conduction velocities at every point of the 
surface (dDistance/dt).  The median conduction velocity was reported. 
7.12 Timothy Syndrome spiral wave defibrillation quantification 
(Figure 5.1) 
Spontaneously occurring spiral waves were identified, and various light patterns were 
projected onto the spiral waves to attempt defibrillation.  In post-processing, defibrillation 
attempts were divided based on two criteria: 1) successful vs failed defibrillation attempts, 
and 2) patterns that illuminated the spiral centers vs patterns that failed to illuminate the 
spiral centers.   
The calcium transient duration was calculated from the movies in post-processing.  For each 
movie, the average calcium fluorescence trace for a 0.5mm x 0.5mm region at the border of 
the frame (away from the center of the spiral) was extracted.  Criteria for minimum peak 
width/height were used to separate actual calcium transients from background noise in each 
fluorescence trace.  The beginning and end of each transient was marked as the time at which 
the fluorescence intensity rose or fell to 10% of the full transient height.  The calcium 
transient duration was calculated as the difference between these two times for each transient.  
An average calcium transient duration was calculated across at least five calcium transients 
occurring before defibrillation attempts started. 
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7.13 Statistical methods 
Two-sample t-tests were used to compute p-values for Figure 4.1D and Figure 5.1E, and a 
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APPENDIX: PUBLISHED WORK 
The work shown here represents one part of my overall PhD work, which was broadly 
located at the intersection of my own personal background in electrical engineering, and the 
expertise of this laboratory in stem cells and tissue engineering.  During my PhD, I had the 
privilege of working with a number of talented individuals on a wide range of projects 
including cardiac tissue engineering and maturation, neuromuscular junction formation, 
immunomodulation, lung regeneration, bioluminescence, image processing, and the work 
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